Psoriasis

Recently published in the British Journal of Dermatology, AbbVie’s phase 4 head-to-head study shows risankizumab demonstrates superiority over apremilast for the treatment of adults with moderate plaque psoriasis.

BOSTON — Among nearly 500 patients with psoriasis in the United States, lower vitamin D levels in blood samples were associated with increasing psoriasis severity, according to research presented at NUTRITION.

Patients with Fitzpatrick skin types IV to VI with plaque psoriasis that were treated with calcipotriene/betamethasone dipropionate 0.005%/0.065% cream achieved similar rates of success as the rest of the population, according to a study.

Patients with autoimmune diseases or long COVID who used a personalized digital care program alongside other non-pharmacologic strategies were more likely to achieve better health-related quality of life scores, according to data.

In this video, George Martin, MD, discusses highlights in the treatment of psoriasis

Ilumetri significantly improved well-being in patients with moderate to severe plaque psoriasis after 16 weeks, Almirall announced in a press release.

An oral interleukin-23 receptor antagonist peptide for adults with moderate to severe plaque psoriasis, JNJ-2113, met all endpoints in an efficacy trial and is now advancing to phase 3, according to a press release.

As age and body weight increased among secukinumab-treated pediatric patients with chronic plaque psoriasis, so did the incidence rate of adverse events, according to pooled safety data from two phase 3 studies.

Spevigo significantly outperformed placebo in reducing the risk for generalized pustular psoriasis flares, Boehringer Ingelheim announced in a press release after its late-breaker session at the 25th World Congress of Dermatology.

M. Elaine Husni, MD, MPH, spoke with Healio about treatment and management options in psoriatic arthritis, including lifestyle changes. “We now have really embraced the concept of wellness strategies,” said Husni, vice chair of rheumatology and director of the Arthritis and Musculoskeletal Center and staff physician in the Orthopedic and Rheumatologic Institute at Cleveland Clinic, and assistant professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.